Back to Results
First PageMeta Content
Pharmaceutical sciences / Business / Pharmacia / Pharmaceutical industry / Mergers and acquisitions / Clinical research / Kano trovafloxacin trial litigation / Pfizer / Corporate crime / Dow Jones Industrial Average


SEC Complaint: Pfizer Inc.
Add to Reading List

Document Date: 2012-08-07 09:39:42


Open Document

File Size: 80,75 KB

Share Result on Facebook

City

Moscow / Perth / New York / Beijing / Lisbon / /

Company

Pfizer Investment Co. LTD / Pfizer HCP Croatia / Defendant Pfizer Inc. / Pfizer China / Pfizer H.C.P. Corporation / Pfizer Inc. / Pharmacia Croatia / Pharmacia Corporation / New York Stock Exchange / vPFIZER INC. / Pfizer Italia S.r.l. / Pfizer HCP Bulgaria / /

Country

Taiwan / Croatia / Italy / Bulgaria / Serbia / Kazakhstan / Russia / Austria / Australia / Slovakia / China / Republic of Italy / Greece / Czech Republic / /

Currency

USD / /

Event

M&A / Reorganization / /

IndustryTerm

indirect wholly-owned subsidiary / manufacturing facility / healthcare institutions / bank account / pharmaceutical / healthcare systems / internal accounting / pharmaceuticals / healthcare professionals / travel agents / indirect majority-owned subsidiary / travel support / pharmaceutical products / healthcare providers / /

Organization

U.S. SECURITIES AND EXCHANGE COMMISSION / Department of Justice / Croatian government / Registration Committee / Czech government / Ministry of Health / Chinese government / /

Position

manager / regional sales manager / manager in early 2004 recommending / Non Consultant / sales representative / marketing manager / representative office / representative / /

Product

Pfizer prescriptions / /

ProvinceOrState

New York / Delaware / /

Technology

cell phones / /

SocialTag